相似文献
1
Drug Discovery in Academia- the third way?
Expert Opin Drug Discov. 2010 Oct 1;5(10):909-19. doi: 10.1517/17460441.2010.506508.
2
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
Cardiovasc Drugs Ther. 2017 Aug;31(4):445-458. doi: 10.1007/s10557-017-6739-9.
3
CNS Drug Discovery in Academia: Where Basic Research Meets Innovation.
Chembiochem. 2024 Oct 1;25(19):e202400397. doi: 10.1002/cbic.202400397. Epub 2024 Jul 3.
4
[Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
Yakugaku Zasshi. 2021 Jun 1;141(6):877-886. doi: 10.1248/yakushi.21-00006. Epub 2021 Mar 1.
5
Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
Hum Reprod. 2017 Aug 1;32(8):1549-1555. doi: 10.1093/humrep/dex230.
6
Guidelines, editors, pharma and the biological paradigm shift.
Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.
7
Making new drugs the hard way.
Adv Pharmacol. 2024;100:1-38. doi: 10.1016/bs.apha.2024.05.002. Epub 2024 Jul 12.
8
Barriers to Alzheimer disease drug discovery and development in academia.
Alzheimer Dis Assoc Disord. 2002;16 Suppl 1:S18-28. doi: 10.1097/00002093-200200001-00004.
9
Accessing external innovation in drug discovery and development.
Expert Opin Drug Discov. 2015 Jun;10(6):579-89. doi: 10.1517/17460441.2015.1040759. Epub 2015 Apr 24.
10
Innovation in neglected tropical disease drug discovery and development.
Infect Dis Poverty. 2018 Jun 18;7(1):67. doi: 10.1186/s40249-018-0444-1.
引用本文的文献
1
Chemsearch: collaborative compound libraries with structure-aware browsing.
Bioinform Adv. 2021 Jul 16;1(1):vbab008. doi: 10.1093/bioadv/vbab008. eCollection 2021.
2
Optimization of Cavity-Based Negative Images to Boost Docking Enrichment in Virtual Screening.
J Chem Inf Model. 2022 Feb 28;62(4):1100-1112. doi: 10.1021/acs.jcim.1c01145. Epub 2022 Feb 8.
3
Monobodies as tool biologics for accelerating target validation and druggable site discovery.
RSC Med Chem. 2021 Sep 13;12(11):1839-1853. doi: 10.1039/d1md00188d. eCollection 2021 Nov 17.
4
In Silico Prediction of Fraction Unbound in Human Plasma from Chemical Fingerprint Using Automated Machine Learning.
ACS Omega. 2021 Mar 5;6(10):6791-6797. doi: 10.1021/acsomega.0c05846. eCollection 2021 Mar 16.
5
Improving target assessment in biomedical research: the GOT-IT recommendations.
Nat Rev Drug Discov. 2021 Jan;20(1):64-81. doi: 10.1038/s41573-020-0087-3. Epub 2020 Nov 16.
6
Natural Products as Modulators of Sirtuins.
Molecules. 2020 Jul 20;25(14):3287. doi: 10.3390/molecules25143287.
7
Translational medicines "Ecosystem".
J Transl Med. 2020 Apr 6;18(1):158. doi: 10.1186/s12967-020-02325-9.
8
The transition to magic bullets - transition state analogue drug design.
Medchemcomm. 2018 Aug 28;9(12):1983-1993. doi: 10.1039/c8md00372f. eCollection 2018 Dec 1.
9
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology.
Cancer Cell. 2017 Jul 10;32(1):9-25. doi: 10.1016/j.ccell.2017.06.005.
10
Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors.
Eur Cell Mater. 2017 May 9;33:279-293. doi: 10.22203/eCM.v033a21.
本文引用的文献
1
Thousands of chemical starting points for antimalarial lead identification.
Nature. 2010 May 20;465(7296):305-10. doi: 10.1038/nature09107.
2
The need for precompetitive integrative bionetwork disease model building.
Clin Pharmacol Ther. 2010 May;87(5):536-9. doi: 10.1038/clpt.2010.40.
3
The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
Clin Pharmacol Ther. 2010 May;87(5):530-3. doi: 10.1038/clpt.2010.27.
4
The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
Clin Pharmacol Ther. 2010 May;87(5):525-7. doi: 10.1038/clpt.2010.29.
5
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.
Nature. 2010 Apr 1;464(7289):728-32. doi: 10.1038/nature08893.
6
A Wellcome experiment in seeding drug discovery.
Nat Rev Drug Discov. 2010 Mar;9(3):178-80. doi: 10.1038/nrd3130.
7
How to improve R&D productivity: the pharmaceutical industry's grand challenge.
Nat Rev Drug Discov. 2010 Mar;9(3):203-14. doi: 10.1038/nrd3078. Epub 2010 Feb 19.
8
Pharmaceutical sciences in 2020.
Nat Rev Drug Discov. 2010 Feb;9(2):99-100. doi: 10.1038/nrd3087.
9
Highlights in the discovery of antiviral drugs: a personal retrospective.
J Med Chem. 2010 Feb 25;53(4):1438-50. doi: 10.1021/jm900932g.
10
HTS and hit finding in academia--from chemical genomics to drug discovery.
Drug Discov Today. 2009 Dec;14(23-24):1150-8. doi: 10.1016/j.drudis.2009.09.004. Epub 2009 Sep 28.
Zotero 插件